Syntaxin 18 inhibitors belong to a class of chemical compounds that have gained recognition in the field of cell biology and intracellular membrane trafficking research. These inhibitors are specifically designed to target and modulate the activity of Syntaxin 18, a soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) protein localized in the endoplasmic reticulum (ER). SNARE proteins are crucial components of the cellular machinery responsible for membrane fusion events, a fundamental process in intracellular trafficking and vesicle-mediated transport. Syntaxin 18, in particular, plays a key role in ER membrane fusion events that are essential for proper protein trafficking and lipid metabolism within the ER.
Syntaxin 18 inhibitors exert their effects by interfering with the interactions and assembly of SNARE complexes involving Syntaxin 18, disrupting its role in ER membrane fusion processes. This interference can lead to perturbations in ER homeostasis, affecting protein secretion, lipid synthesis, and the overall functioning of the secretory pathway. Researchers employ Syntaxin 18 inhibitors as valuable tools to investigate the specific roles of Syntaxin 18 in various cellular contexts and to gain insights into the molecular mechanisms underlying ER membrane fusion and intracellular transport. While the precise applications and broader implications of Syntaxin 18 inhibitors are subjects of ongoing research, their utility in elucidating the intricacies of membrane trafficking and organelle communication within the cell is of paramount importance in advancing our understanding of cell biology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits eukaryotic protein translation, which could reduce the levels of Syntaxin 18. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA and inhibits RNA synthesis which could decrease Syntaxin 18 mRNA production. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a pathway that regulates protein synthesis, potentially reducing Syntaxin 18 expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin specifically inhibits RNA polymerase II, potentially decreasing the mRNA levels of Syntaxin 18. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin can inhibit RNA synthesis by binding to RNA polymerase, potentially reducing Syntaxin 18 expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine can raise endosomal pH, which might affect the trafficking of molecules that regulate Syntaxin 18 expression. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin causes premature termination of mRNA translation, which can lead to reduced Syntaxin 18 protein levels. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $440.00 $900.00 $1400.00 $2502.00 | ||
Emetine inhibits eukaryotic protein synthesis at the level of translation elongation, affecting Syntaxin 18 levels. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB inhibits RNA synthesis by targeting RNA polymerase II, which could decrease Syntaxin 18 mRNA levels. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits DNA topoisomerase I, leading to DNA damage responses that could affect Syntaxin 18 expression. | ||||||